Development of an injectable formulation of albendazole and in vivo evaluation of its efficacy against Echinococcus multilocularis metacestode
- 31 December 1995
- journal article
- Published by Elsevier in International Journal for Parasitology
- Vol. 25 (12) , 1437-1441
- https://doi.org/10.1016/0020-7519(95)00055-0
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- In vitro quantitative assessment of Echinococcus multilocularis metacestode viability after in vivo and in vitro maintenanceInternational Journal for Parasitology, 1995
- Experience with doxorubicin-bound polyisohexylcyanoacrylate nanoparticles on murine alveolar echinococcosis of the liverInternational Journal for Parasitology, 1993
- Effect of surfactants on Albendazole absorptionJournal of Pharmaceutical and Biomedical Analysis, 1991
- Dexamethasone increases plasma levels of albendazoleZeitschrift für Neurologie, 1990
- Albendazole kinetics in patients with echinococcosis: Delayed absorption and impaired elimination in cholestasisEuropean Journal of Clinical Pharmacology, 1990
- Increased systemic availability of albendazole when taken with a fatty mealEuropean Journal of Clinical Pharmacology, 1988
- A comparison of the effects of albendazole, its sulphone metabolite, and mebendazole on the viability of protoscoleces of Echinococcus granulosus in an in vitro culture systemTransactions of the Royal Society of Tropical Medicine and Hygiene, 1987
- Effect of albendazole sulphoxide on viability of hydatid protoscoleces in vitroTransactions of the Royal Society of Tropical Medicine and Hygiene, 1986
- Experimental alveolar echinococcosis. Suitability of a murine model of intrahepatic infection byEchinococcus multilocularis for immunological studiesCellular and Molecular Life Sciences, 1984
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983